AAAAAA
Results:
1-23
|
Results: 23
Authors:
Hillman, GG
Forman, JD
Kucuk, O
Yudelev, M
Maughan, RL
Rubio, J
Layer, A
Tekyi-Mensah, S
Abrams, J
Sarkar, FH
Citation: Gg. Hillman et al., Genistein potentiates the radiation effect on prostate carcinoma cells, CLIN CANC R, 7(2), 2001, pp. 382-390
Authors:
Kucuk, O
Sarkar, FH
Sakr, W
Djuric, Z
Pollak, MN
Khachik, F
Li, YW
Banerjee, M
Grignon, D
Bertram, JS
Crissman, JD
Pontes, EJ
Wood, DP
Citation: O. Kucuk et al., Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy, CANC EPID B, 10(8), 2001, pp. 861-868
Authors:
Sahin, K
Kucuk, O
Sahin, N
Citation: K. Sahin et al., Effects of dietary chromium picolinate supplementation on performance and plasma concentrations of insulin and corticosterone in laying hens under low ambient temperature, J ANIM PHYS, 85(5-6), 2001, pp. 142-147
Authors:
Davis, JN
Kucuk, O
Djuric, Z
Sarkar, FH
Citation: Jn. Davis et al., Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes, FREE RAD B, 30(11), 2001, pp. 1293-1302
Authors:
Sahin, K
Sahin, N
Onderci, M
Yaralioglu, S
Kucuk, O
Citation: K. Sahin et al., Protective role of supplemental vitamin E on lipid peroxidation, vitamins E, A and some mineral concentrations of broilers reared under heat stress, VET MED-CZ, 46(5), 2001, pp. 140-144
Authors:
Djuric, Z
Chen, G
Doerge, DR
Heilbrun, LK
Kucuk, O
Citation: Z. Djuric et al., Effect of soy isoflavone supplementation on markers of oxidative stress inmen and women, CANCER LETT, 172(1), 2001, pp. 1-6
Authors:
Sahin, K
Kucuk, O
Sahin, N
Ozbey, O
Citation: K. Sahin et al., Effects of dietary chromium picolinate supplementation on egg production, egg quality and serum concentrations of insulin, corticosterone, and some metabolites of Japanese quails, NUTR RES, 21(9), 2001, pp. 1315-1321
Authors:
Kucuk, O
Fisher, E
Moinpour, CM
Coleman, D
Hussain, MHA
Sartor, AO
Chatta, GS
Lowe, BA
Eisenberger, MA
Crawford, ED
Citation: O. Kucuk et al., Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: A Southwest Oncology Group Study (SWOG 9235), UROLOGY, 58(1), 2001, pp. 53-58
Authors:
Fleshner, NE
Kucuk, O
Citation: Ne. Fleshner et O. Kucuk, Antioxidant dietary supplements: Rationale and current status as chemopreventive agents for prostate cancer, UROLOGY, 57(4A), 2001, pp. 90-94
Authors:
Kalayci, AG
Kansu, A
Girgin, N
Kucuk, O
Aras, G
Citation: Ag. Kalayci et al., Bone mineral density and importance of a gluten-free diet in patients withceliac disease in childhood, PEDIATRICS, 108(5), 2001, pp. NIL_78-NIL_82
Authors:
Kucuk, O
Hess, BW
Ludden, PA
Rule, DC
Citation: O. Kucuk et al., Effect of forage : concentrate ratio on ruminal digestion and duodenal flow of fatty acids in ewes, J ANIM SCI, 79(8), 2001, pp. 2233-2240
Authors:
Davis, JN
Muqim, N
Bhuiyan, M
Kucuk, O
Pienta, KJ
Sarkar, FH
Citation: Jn. Davis et al., Inhibition of prostate specific antigen expression by genistein in prostate cancer cells, INT J ONCOL, 16(6), 2000, pp. 1091-1097
Authors:
Kucuk, O
Shevrin, DH
Pandya, KJ
Bonomi, PD
Citation: O. Kucuk et al., Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer - An Eastern Cooperative Oncology Group study (PB586), AM J CL ONC, 23(4), 2000, pp. 371-375
Authors:
Kucuk, O
Kilton, L
Wade, JL
Blough, R
Benson, AB
Citation: O. Kucuk et al., Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia, AM J CL ONC, 23(4), 2000, pp. 379-383
Authors:
Kucuk, O
Young, ML
Habermann, TM
Wolf, BC
Jimeno, J
Cassileth, PA
Citation: O. Kucuk et al., Phase II trial of didemnin B in previously treated non-Hodgkin's lymphoma - An Eastern Cooperative Oncology Group (ECOG) study, AM J CL ONC, 23(3), 2000, pp. 273-277
Authors:
Trivedi, C
Redman, B
Flaherty, LE
Kucuk, O
Wei, D
Heilbrun, LK
Citation: C. Trivedi et al., Weekly 1-hour infusion of paclitaxel: clinical feasibility and efficacy inpatients with hormone-refractory prostate carcinoma. (vol 89, pg 431, 2000), CANCER, 89(6), 2000, pp. 1412-1412
Authors:
Trivedi, C
Redman, B
Flaherty, LE
Kucuk, O
Du, W
Heilbrun, LK
Hussain, M
Citation: C. Trivedi et al., Weekly 1-hour infusion of paclitaxel - Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma, CANCER, 89(2), 2000, pp. 431-436
Authors:
Kucuk, O
Aras, G
Soylu, A
Gurler, A
Tulunay, O
Ormeci, N
Duzgun, N
Bengi, N
Ibis, E
Akin, A
Citation: O. Kucuk et al., Evaluation of gastrointestinal involvement of Behcet's disease by nuclear medical techniques, ANN NUCL M, 13(4), 1999, pp. 211-214
Authors:
Jaszewski, R
Khan, A
Sarkar, FH
Kucuk, O
Tobi, M
Zagnoon, A
Dhar, R
Kinzie, J
Majumdar, APN
Citation: R. Jaszewski et al., Folic acid inhibition of EGFR-mediated proliferation in human colon cancercell lines, AM J P-CELL, 277(6), 1999, pp. C1142-C1148
Authors:
Aslakson, CJ
Lee, G
Boomer, JS
Gilman-Sachs, A
Kucuk, O
Beaman, KD
Citation: Cj. Aslakson et al., Expression of regeneration and tolerance factor on B cell chronic lymphocytic leukemias: A possible mechanism for escaping immune surveillance, AM J HEMAT, 61(1), 1999, pp. 46-52
Authors:
Kucuk, O
Pandya, KJ
Skeel, RT
Hochster, H
Abeloff, MD
Citation: O. Kucuk et al., Phase II study of cisplatin and 5-fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185), BREAST CANC, 57(2), 1999, pp. 201-206
Authors:
Davis, JN
Kucuk, O
Sarkar, FH
Citation: Jn. Davis et al., Genistein inhibits NF-kappa B activation in prostate cancer cells, NUTR CANCER, 35(2), 1999, pp. 167-174
Authors:
Hussain, M
Gadgeel, S
Kucuk, O
Du, W
Salwen, W
Ensley, J
Citation: M. Hussain et al., Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck, CANCER, 86(11), 1999, pp. 2364-2369
Risultati:
1-23
|